CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 26 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $921,590 | -27.5% | 1,125,262 | 0.0% | 0.00% | – |
| Q2 2023 | $1,271,546 | +13.0% | 1,125,262 | 0.0% | 0.00% | – |
| Q1 2023 | $1,125,149 | +15.2% | 1,125,262 | 0.0% | 0.00% | – |
| Q4 2022 | $976,502 | -46.9% | 1,125,262 | -21.1% | 0.00% | – |
| Q3 2022 | $1,840,000 | +47.3% | 1,426,428 | -0.6% | 0.00% | – |
| Q2 2022 | $1,249,000 | -81.5% | 1,434,960 | -35.8% | 0.00% | – |
| Q1 2022 | $6,755,000 | -38.8% | 2,236,392 | +4.3% | 0.00% | – |
| Q4 2021 | $11,041,000 | -81.4% | 2,143,760 | -12.5% | 0.00% | -100.0% |
| Q3 2021 | $59,366,000 | +23.7% | 2,450,065 | -0.3% | 0.00% | +100.0% |
| Q2 2021 | $48,007,000 | +5.9% | 2,458,132 | +0.3% | 0.00% | 0.0% |
| Q1 2021 | $45,332,000 | – | 2,450,390 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 597,678 | $771,000 | 0.24% |
| Kynam Capital Management, LP | 739,649 | $954,000 | 0.20% |
| RA Capital Management | 6,991,003 | $9,018,000 | 0.19% |
| Octagon Capital Advisors LP | 450,000 | $581,000 | 0.10% |
| Ikarian Capital, LLC | 219,501 | $283,000 | 0.06% |
| UBS OCONNOR LLC | 613,931 | $792,000,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,277,519 | $1,648,000 | 0.00% |
| ROCKY MOUNTAIN ADVISERS, LLC | 1,200 | $2,000 | 0.00% |
| CSS LLC/IL | 38,721 | $50,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 26,867 | $35,000 | 0.00% |